1-1banner
 
medpundit
 

 
Commentary on medical news by a practicing physician.
 

 
Google
  • Epocrates MedSearch Drug Lookup




  • MASTER BLOGS





    "When many cures are offered for a disease, it means the disease is not curable" -Anton Chekhov




    ''Once you tell people there's a cure for something, the more likely they are to pressure doctors to prescribe it.''
    -Robert Ehrlich, drug advertising executive.




    "Opinions are like sphincters, everyone has one." - Chris Rangel



    email: medpundit-at-ameritech.net

    or if that doesn't work try:

    medpundit-at-en.com



    Medpundit RSS


    Quirky Museums and Fun Stuff


    Who is medpundit?


    Tech Central Station Columns



    Book Reviews:
    Read the Review

    Read the Review

    Read the Review

    More Reviews

    Second Hand Book Reviews

    Review


    Medical Blogs

    rangelMD

    DB's Medical Rants

    Family Medicine Notes

    Grunt Doc

    richard[WINTERS]

    code:theWebSocket

    Psychscape

    Code Blog: Tales of a Nurse

    Feet First

    Tales of Hoffman

    The Eyes Have It

    medmusings

    SOAP Notes

    Obels

    Cut-to -Cure

    Black Triangle

    CodeBlueBlog

    Medlogs

    Kevin, M.D

    The Lingual Nerve

    Galen's Log

    EchoJournal

    Shrinkette

    Doctor Mental

    Blogborygmi

    JournalClub

    Finestkind Clinic and Fish Market

    The Examining Room of Dr. Charles

    Chronicles of a Medical Mad House

    .PARALLEL UNIVERSES.

    SoundPractice

    Medgadget
    Health Facts and Fears

    Health Policy Blogs

    The Health Care Blog

    HealthLawProf Blog

    Facts & Fears

    Personal Favorites

    The Glittering Eye

    Day by Day

    BioEdge

    The Business Word Inc.

    Point of Law

    In the Pipeline

    Cronaca

    Tim Blair

    Jane Galt

    The Truth Laid Bear

    Jim Miller

    No Watermelons Allowed

    Winds of Change

    Science Blog

    A Chequer-Board of Night and Days

    Arts & Letters Daily

    Tech Central Station

    Blogcritics

    Overlawyered.com

    Quackwatch

    Junkscience

    The Skeptic's Dictionary



    Recommended Reading

    The Doctor Stories by William Carlos Williams


    Pox Americana: The Great Smallpox Epidemic of 1775-82 by Elizabeth Fenn


    Intoxicated by My Illness by Anatole Broyard


    Raising the Dead by Richard Selzer


    Autobiography of a Face by Lucy Grealy


    The Man Who Mistook His Wife for a Hat by Oliver Sacks


    The Sea and Poison by Shusaku Endo


    A Midwife's Tale by Laurel Thatcher Ulrich




    MEDICAL LINKS

    familydoctor.org

    American Academy of Pediatrics

    General Health Info

    Travel Advice from the CDC

    NIH Medical Library Info

     



    button

    Tuesday, September 05, 2006

    Lipitor Coup, Redux: Remember that recent study that suggested high, expensive doses of Lipitor can prevent strokes? It's a success for Pfizer:

    Pfizer Inc. , the world's largest drug company, is using the results of a study it sponsored to persuade doctors to switch patients to pricier doses of its blockbuster drug, Lipitor . And according to the latest sales figures, the marketing pitch is working.

    ...For the week ending Aug. 18 , prescriptions for higher doses of Lipitor jumped 12 percent , according to John Boris , a Bear Stearns analyst, promising a 2 percent revenue increase for Lipitor for the third quarter .

    The Pfizer-sponsored study on Lipitor's impact on stroke was written by 11 authors who were either company employees or reported financial ties to it. The New England Journal of Medicine article linked daily , 80 milligram Lipitor doses with a 16 percent reduction in the risk of a repeat stroke.

    An editorial, also published last month in the journal, could provide another driver for Lipitor revenue growth. The study adds to ``gathering momentum" that could convince insurers to count statin use as a measure of ``quality" after-stroke care, according to the editorial. Dr. David M. Kent , the editorial's author, reported receiving grant support from Pfizer .


    I don't mind saying I told you so. American medicine - doing our best to keep your healthcare expensive.

    Addendum: Another past post on the Lipitor marketing-disguised-as-research maneuvers.
     

    posted by sydney on 9/05/2006 07:57:00 AM 2 comments

    2 Comments:

    Doctors have to be mindful that pharma is going to loose $40B in sales over the next few years to generics. They will only try harder, and with more deception, to hold onto those sales to maintain stock prices, and stock option income.

    The worse is yet to come.

    Steve Lucas

    By Anonymous Anonymous, at 3:06 PM  

    A careful look at the study that Pfizer is now using, according to the Boston Globe, to market high-dose Lipitor is even more troubling. The death rate of patients on Lipitor was slightly higher than the rate on placebo. See this post on Health Care Renewal:
    http://hcrenewal.blogspot.com/2006/09/should-physicians-prescribe-high-dose.html/

    By Blogger Roy M. Poses MD, at 1:41 PM  

    Post a Comment

    This page is powered by Blogger, the easy way to update your web site.

    Main Page

    Ads

    Home   |   Archives

    Copyright 2006